Xu D. et al Transl Res. 2023 A diagnostic model based on DNA methylation haplotype block characteristics for identifying papillary thyroid carcinoma from thyroid adenoma. doi:10.1016/j.trsl.2023.10.001
Sun J. et al Clin Epigenetics. 2023 Cross-platform comparisons for targeted bisulfite sequencing of MGISEQ-2000 and NovaSeq6000. doi:10.1186/s13148-023-01543-4
Wang Z. et al Respir Res. 2023 Early detection and stratification of lung cancer aided by a cost-effective assay targeting circulating tumor DNA (ctDNA) methylation. doi:10.1186/s12931-023-02449-8
Mo S. et al JAMA Oncol. 2023 Early Detection of Molecular Residual Disease and Risk Stratification for Stage I to III Colorectal Cancer via Circulating Tumor DNA Methylation. doi:10.1001/jamaoncol.2023.0425
Hong S. et al EBioMedicine. 2023 Cell-free DNA methylation biomarker for the diagnosis of papillary thyroid carcinoma. doi:10.1016/j.ebiom.2023.104497
Chen S. et al BMC Genomics. 2022 Investigating the genomic alteration improved the clinical outcome of aged patients with lung carcinoma. doi:10.1186/s12864-021-08289-4
Liu J. et al Front Oncol. 2021 Genetic Alteration Profiling of Chinese Lung Adenocarcinoma and Its Effect on Targeted Therapy Efficacy. doi:10.3389/fonc.2021.726547
Wang Z. Li Z. et al Nat Commun. 2021 Deciphering cell lineage specification of human lung adenocarcinoma with single-cell RNA sequencing. doi:10.1038/s41467-021-26770-2
Cai G. et al Gastroenterology. 2021 A Multilocus Blood-Based Assay Targeting Circulating Tumor DNA Methylation Enables Early Detection and Early Relapse Prediction of Colorectal Cancer. doi:10.1053/j.gastro.2021.08.054
Jia Z. et al Clin Epigenetics. 2021 DNA methylation patterns at and beyond the histological margin of early-stage invasive lung adenocarcinoma radiologically manifested as pure ground-glass opacity. doi:10.1186/s13148-021-01140-3
Zhou Y. et al Ann Transl Med. 2021 Novel ETV1 mutation in small cell lung cancer transformation resistant to EGFR tyrosine kinase inhibitors. doi:10.21037/atm-21-2625
Xiong Y. et al Virchows Arch. 2021 Application of biomarkers in the diagnosis of uncertain samples of core needle biopsy of thyroid nodules. doi:10.1007%2Fs00428-021-03161-y
Zhang H. et al J Clin Endocrinol Metab. 2021 DNA Methylation Haplotype Block Markers Efficiently Discriminate Follicular Thyroid Carcinoma from Follicular Adenoma. doi:10.1210/clinem/dgaa950
Chen X. et al Nat Comm. 2020 Non-invasive early detection of cancer four years before conventional diagnosis using a blood test. doi: 10.1038/s41467-020-17316-z
Guo S. et al Nat Genet. 2017 Identification of methylation haplotype blocks aids in deconvolution of heterogeneous tissue samples and tumor tissue-of-origin mapping from plasma DNA. doi: 10.1038/ng.3805
BLUEPRINT consortium. Nat Biotechnol. 2016 Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. doi: 10.1038/nbt.3605
Gole J. et al Nat Biotechnol. 2013 Massively parallel polymerase cloning and genome sequencing of single cells using nanoliter microwells. doi: 10.1038/nbt.2720
Ruiz S. et al. Proc Natl Acad Sci U S A. 2012 Identification of a specific reprogramming-associated epigenetic signature in human induced pluripotent stem cells. doi: 10.1073/pnas.1202352109
Diep D. et al Nature Meth 2012 Library-free methylation sequencing with bisulfite padlock probes. doi: 10.1038/nmeth.1871
Gore A. et al Nature 2011 Somatic coding mutations in human induced pluripotent stem cells. doi: 10.1038/nature09805
Shoemaker R. et al. Genome Res. 2010. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. doi: 10.1101/gr.104695.109
Deng J. et al. Nat Biotechnol. 2009. Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. doi: 10.1038/nbt.1530
